Cia Tecidos Santanense (CTSA3F) Quote

Republican wunderkind who helped Trump win Pennsylvania sets sights on flipping another long-blue state

https://nypost.com/2024/12/07/us-news/republican-who-helped-trump-win-pennsylvania-sets-sights-on-nj/

“ I’m enjoying this DJT stock demise”.
Does that make me a bad person? Well at minimal statement is very telling! Furthermore, it puts you on the wrong side of history. DJT will not only survive, it will THRIVE!

Was there an R/S back in July? It jumped from these kinds of levels to over $4 pps. in about a day.

This board is for talking about DBMM. About discussing the issues with DBMM. About giving opinions on whether it's a good investment or a terrible investment.

My opinion is that it's a horrible investment. I show WHY I think it is. I use financials and real numbers to back up my o

NASDAQ PRESIDENT TAL COHEN SAYS NASDAQ WILL ENABLE 24-HOUR TRADING; ANTICIPATE TIMELINE BEING IN THE SECOND HALF OF 2026 - LINKEDIN POST

This is actually trading around $130. They need another round of reduced mortgage rates to skyrocket again.

Republican wunderkind who helped Trump win Pennsylvania sets sights on flipping another long-blue state

https://nypost.com/2024/12/07/us-news/republican-who-helped-trump-win-pennsylvania-sets-sights-on-nj/

As a Holding company, RNVA knows its subsidiary needs money for assisted livings. Are we going to see some capital contributions?? 3000-4500$ approximately 12m profitable rev. Its just the beginning. Billion dollar company?? By 2060, estimated 100m seniors. Naked shorts dont want FOXO to RS. Kee

February U.S. nonfarm payrolls rise 151,000, unemployment rate rises to 4.1%

@XMarket News

BREAKING🚨 Court Issues Subpoena to Ken Griffin's Citadel, Seeking Information on Potential Naked Short Selling

- Court Requests Citadel’s Position Data on Meta Materials and $MMTLP, Probing for Evidence of Naked Short Selling

https:/

Eggs are not sold refrigerated here, in fact the top chefs say NEVER refrigerate eggs.

Having said that, my wife always puts them in the fridge.

I just don't care enough about eggs to get into a discussion about it. 😉

Dude they are literally replying to an Isopet post.

Top 15 at 8:30
https://ih.advfn.com/markets/nasdaq/premarket

~~COMPX 3/7/2025~~~~~~~

Previous Close

18069.26 -483.48

18199 BullNBear52
18285 SSKILLZ1

$COEP Coeptis Therapeutics "We're thrilled to announce the successful closure of our second Series A Preferred financing," said Brian Cogley, CFO of COEPTIS. "This funding is pivotal as we expand our operational capabilities and enhance shareholder value through our new Technology Division. #COEPTIS

$COEP Coeptis Therapeutics "We're thrilled to announce the successful closure of our second Series A Preferred financing," said Brian Cogley, CFO of COEPTIS. "This funding is pivotal as we expand our operational capabilities and enhance shareholder value through our new Technology Division. #COEPTIS

A local should go jiggle the locked door and give us some pictures.

CGON
CG Oncology assumed with an Overweight at Morgan Stanley
Morgan Stanley assumed coverage of CG Oncology with an Overweight rating and $55 price target. Morgan Stanley sees a competitive profile for cretostimogene in bladder cancer, with indication expansion potential beyond hig

Nasdaq: $CYCU, a trusted leader in IT cybersecurity solutions and AI, announced a nationwide expansion of its strategic partnership with CentralSquare Technologies, LLC to deliver its IT services across the country. https://finance.yahoo.com/news/cycurion-nasdaq-cycu-partners-centralsquare-134500799

Maybe a dead rabbit? Would be nice if Eutectix could step in a s the domestic manufacturer.

Nasdaq: $CYCU, a trusted leader in IT cybersecurity solutions and AI, announced a nationwide expansion of its strategic partnership with CentralSquare Technologies, LLC to deliver its IT services across the country. https://finance.yahoo.com/news/cycurion-nasdaq-cycu-partners-centralsquare-134500799

CGON
CG Oncology assumed with an Overweight at Morgan Stanley
Morgan Stanley assumed coverage of CG Oncology with an Overweight rating and $55 price target. Morgan Stanley sees a competitive profile for cretostimogene in bladder cancer, with indication expansion potential beyond hig

nvni- .2465

$BURU -HUMBL, Inc. Announces $2 Million Share Exchange Agreement and Strategic Partnership With NUBURU, Inc. to Accelerate Growth and Shareholder Value
https://finance.yahoo.com/news/humbl-inc-announces-2-million-230000447.html

$BURU -HUMBL, Inc. Announces $2 Million Share Exchange Agreement and Strategic Partnership With NUBURU, Inc. to Accelerate Growth and Shareholder Value
https://finance.yahoo.com/news/humbl-inc-announces-2-million-230000447.html